OABI
OmniAb, Inc. NASDAQ Listed Sep 30, 2021$1.47
Mkt Cap $167.3M
52w Low $1.22
23.3% of range
52w High $2.29
50d MA $1.63
200d MA $1.74
P/E (TTM)
-2.5x
EV/EBITDA
-4.1x
P/B
0.6x
Debt/Equity
0.1x
ROE
-24.3%
P/FCF
-5.7x
RSI (14)
—
ATR (14)
—
Beta
0.87
50d MA
$1.63
200d MA
$1.74
Avg Volume
405.0K
OmniAb, Inc., a biotechnology company, provides therapeutic antibody discovery technologies in the United States. The company's discovery platform provides industry partners access to the diverse antibody repertoires and screening technologies to enable discovery of next-generation therapeutics. Its OmniAb platform is the biological intelligence of proprietary transgenic animals, including OmniRat, OmniChicken, and OmniMouse that have been genetically modified to generate antibodies with human sequences to facilitate development of human therapeutic candidates. The company's OmniFlic (transgenic rat) and OmniClic (transgenic chicken) address industry needs for bispecific antibody applications though a common light chain approach, and OmniTaur that features unique structural attributes of cow antibodies for complex targets. The company was founded in 2012 and is headquartered in Emeryville, California.
CIK (SEC)
Phone
510 250 7800
5980 Horton Street · EmeryVille, CA 94608 · US
| Date | Time | Est | Rptd | Surp | Base | Gap% | D1% | D2% | D3% | D4% | D5% | Guide ▲★ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 4, 2026 | AMC | -0.08 | -0.11 | -37.5% | 1.81 | +0.0% | +10.5% | +4.4% | +7.7% | +9.9% | +8.3% | — |
| Nov 4, 2025 | AMC | -0.14 | -0.14 | -2.9% | 1.48 | -2.7% | -3.4% | -6.8% | -6.8% | +0.7% | +8.8% | — |
| Aug 6, 2025 | AMC | -0.14 | -0.15 | -7.1% | 1.93 | -1.0% | -2.6% | +2.1% | +1.6% | +1.6% | +6.2% | — |
| May 8, 2025 | AMC | -0.17 | -0.17 | +0.0% | 1.57 | -0.6% | -8.3% | -8.9% | -10.8% | -3.2% | -1.3% | — |
| Mar 18, 2025 | AMC | -0.13 | -0.12 | +7.7% | 3.19 | -4.4% | -20.4% | -28.8% | -20.7% | -20.4% | -23.5% | — |
| Nov 12, 2024 | AMC | -0.14 | -0.16 | -14.3% | 4.49 | -10.9% | -9.4% | -9.4% | -13.6% | -17.1% | -14.5% | — |
| Aug 8, 2024 | AMC | -0.18 | -0.13 | +27.8% | 4.29 | +5.4% | -1.2% | -3.7% | -0.7% | -4.2% | -1.6% | — |
| May 9, 2024 | AMC | -0.17 | -0.19 | -11.8% | 4.57 | -3.5% | +2.4% | -2.0% | -1.5% | -0.7% | -0.4% | — |
| Mar 20, 2024 | AMC | -0.17 | -0.14 | +17.6% | 5.42 | +5.5% | -5.2% | -5.4% | -2.0% | -4.2% | -0.6% | — |
| Nov 9, 2023 | AMC | -0.14 | -0.16 | -14.3% | 4.36 | +4.4% | -2.8% | +1.6% | +8.0% | +6.4% | +2.1% | — |
| Aug 10, 2023 | AMC | -0.11 | -0.15 | -36.4% | 5.78 | +0.0% | -5.5% | -5.7% | -3.6% | +2.6% | +1.2% | — |
| May 11, 2023 | AMC | 0.05 | -0.06 | -220.0% | 3.23 | +5.3% | +8.4% | +8.7% | +18.6% | +20.1% | +21.4% | — |
| Date | Firm | Action | Grade | Target | Base | Open | Gap% | D1% | D2% | D3% | D4% | D5% |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Aug 7 | RBC Capital | Maintains | Outperform → Outperform | — | $1.93 | $1.91 | -1.0% | -2.6% | +2.1% | +1.6% | +1.6% | +6.2% |
| May 12 | Benchmark | Maintains | Buy → Buy | — | $1.44 | $1.48 | +2.8% | -0.7% | -2.8% | +5.6% | +7.6% | +9.7% |
| Mar 27 | RBC Capital | Maintains | Outperform → Outperform | — | $2.43 | $2.42 | -0.4% | +1.6% | -0.4% | -1.2% | -6.2% | -4.9% |
| Mar 20 | Benchmark | Maintains | Buy → Buy | — | $2.54 | $2.55 | +0.4% | -10.6% | -0.4% | +0.0% | -3.9% | -4.3% |
| Mar 19 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $3.19 | $3.05 | -4.4% | -20.4% | -28.8% | -20.7% | -20.4% | -23.5% |
| Nov 14 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $4.07 | $4.07 | +0.0% | +0.0% | -4.7% | -8.6% | -5.7% | -4.2% |
| Nov 14 | Benchmark | Maintains | Buy → Buy | — | $4.07 | $4.07 | +0.0% | +0.0% | -4.7% | -8.6% | -5.7% | -4.2% |
| Aug 19 | Benchmark | Maintains | Buy → Buy | — | $4.18 | $4.17 | -0.2% | +0.7% | -0.2% | -0.2% | -2.6% | +2.4% |
| Aug 16 | RBC Capital | Maintains | Outperform → Outperform | — | $4.22 | $4.22 | +0.0% | -0.9% | -0.2% | -1.2% | -1.2% | -3.6% |
| Aug 12 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $4.24 | $4.25 | +0.2% | -2.6% | +0.5% | -3.1% | -0.5% | -1.4% |
| May 14 | Benchmark | Maintains | Buy → Buy | — | $4.48 | $4.52 | +0.9% | +0.4% | +1.3% | +1.6% | -0.7% | -2.0% |
| Mar 26 | Truist | Maintains | Buy → Buy | — | $5.31 | $5.34 | +0.6% | -2.3% | +1.5% | +2.1% | +0.9% | -0.6% |
| Mar 22 | Benchmark | Maintains | Buy → Buy | — | $5.14 | $5.14 | +0.0% | -0.2% | +3.3% | +1.0% | +4.9% | +5.4% |
| Mar 21 | RBC Capital | Maintains | Outperform → Outperform | — | $5.42 | $5.72 | +5.5% | -5.2% | -5.4% | -2.0% | -4.2% | -0.6% |
| Mar 21 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $5.42 | $5.72 | +5.5% | -5.2% | -5.4% | -2.0% | -4.2% | -0.6% |
| Nov 14 | Benchmark | Maintains | Buy → Buy | — | $4.43 | $4.56 | +2.9% | +6.3% | +4.7% | +0.5% | +0.5% | +2.0% |
| Aug 11 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $5.78 | $5.78 | +0.0% | -5.5% | -5.7% | -3.6% | +2.6% | +1.2% |
| May 12 | Benchmark | Maintains | Buy → Buy | — | $3.23 | $3.40 | +5.3% | +8.4% | +8.7% | +18.6% | +20.1% | +21.4% |
| Apr 21 | Benchmark | Maintains | Buy → Buy | — | $3.59 | $3.60 | +0.3% | +8.1% | +1.4% | -3.1% | -2.5% | -3.1% |
| Apr 13 | Craig-Hallum | Maintains | Buy → Buy | — | $3.81 | $3.93 | +3.1% | +0.5% | -0.5% | -3.4% | -8.1% | -5.8% |
| Mar 31 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $3.51 | $4.12 | +17.4% | +4.8% | +4.3% | +5.4% | +5.4% | +6.8% |
| Feb 22 | Cowen & Co. | Maintains | Outperform → Outperform | — | $3.86 | $4.01 | +3.9% | +2.3% | +2.3% | +2.8% | +3.4% | +8.0% |
| Feb 13 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $3.88 | $4.15 | +7.1% | -1.5% | -1.2% | -1.9% | -4.5% | -5.0% |
| Dec 20 | Truist | Maintains | Buy → Buy | — | $3.24 | $3.28 | +1.2% | +1.9% | +19.1% | +12.3% | +9.9% | +14.5% |
| Dec 16 | Credit Suisse | Maintains | Outperform → Outperform | — | $3.46 | $3.67 | +6.1% | +0.9% | -6.4% | -4.6% | +11.6% | +5.2% |
| Nov 29 | SVB Leerink | Maintains | Outperform → Outperform | — | $2.88 | $2.93 | +1.7% | -1.4% | +22.9% | +16.3% | +37.8% | +35.4% |
| Nov 28 | Stifel | Maintains | Buy → Buy | — | $2.61 | $2.68 | +2.7% | +10.3% | +8.8% | +35.6% | +28.4% | +52.1% |
No insider trades available.
Data updated apr 26, 2026 4:43pm
· Source: massive.com